Craig R. Rayner, PRESIDENT, INTEGRATED DRUG Development at Certara, Inc. (CERT), sold 106,824 shares at $34.15 ($3.9M) on 2021-09-02, disclosed to the SEC on 2021-09-07.
Open-market sale of $3.9M CERT by PRESIDENT, INTEGRATED DRUG Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.51 | 3,900 | $131K | 3.4% |
| 2 | $33.51 | 3,900 | $131K | 3.4% |
| 3 | $34.15 | 1,900 | $65K | 1.7% |
| 4 | $36.64 | 48,462 | $1.8M | 45.7% |
| 5 | $36.64 | 48,462 | $1.8M | 45.7% |
| 6 | $37.21 | 200 |
| $7K |
| 0.2% |
| Total | $36.37 avg | 106,824 | $3.9M | 100% |